# Investigating tDCS as a Treatment for Unipolar and Bipolar Depression

> **NCT01562184** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of New South Wales** · enrollment: 120 (actual)

## Conditions studied

- Unipolar Depression
- Bipolar Depression

## Interventions

- **DEVICE:** Sham tDCS device
- **DEVICE:** Soterix tDCS device

## Key facts

- **NCT ID:** NCT01562184
- **Lead sponsor:** The University of New South Wales
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2015-12-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562184, "Investigating tDCS as a Treatment for Unipolar and Bipolar Depression". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01562184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*